No Data
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Express News | Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Several Insiders Invested In Gossamer Bio Flagging Positive News
12 Health Care Stocks Moving In Wednesday's After-Market Session
Bullish Outlook on Gossamer Bio's Seralutinib Efficacy and Market Potential
Oppenheimer Maintains Gossamer Bio(GOSS.US) With Buy Rating, Raises Target Price to $9
Oppenheimer analyst Andreas Argyrides maintains $Gossamer Bio(GOSS.US)$ with a buy rating, and adjusts the target price from $6 to $9.According to TipRanks data, the analyst has a success rate of 49.8
No Data
No Data